QbD Group
    Case Study

    Revolutionizing pharmacovigilance: a success story of strategic partnership and seamless integration

    Discover how QbD Group's expert support enhanced a pharmaceutical company's pharmacovigilance, leading to a favorable inspection outcome by the local Regulatory Authority (AEMPS).

    2024年5月31日2 分钟阅读
    Pharma

    Streamlining operations for a Spanish pharmaceutical company

    A Spanish generic pharmaceutical company, with 90 products currently on the market, reached out to us to outsource all their pharmacovigilance (PV) activities. Initially, we were approached by their Quality Department, and later the CEO got involved. They required a Quality PV but lacked the time to manage it themselves.

    挑战

    Overcoming pharmacovigilance hurdles

    Our client faced significant challenges due to a previous negative experience managing pharmacovigilance (PV) internally. They lacked internal resources and time to effectively implement PV activities. Additionally, there was a notable lack of experience in fulfilling the EU Qualified Person for Pharmacovigilance (EU-QPPV) role.

    方法

    Comprehensive pharmacovigilance management & support services

    QbD Group’s approach involved acting as the Responsible Person for Pharmacovigilance (EU-QPPV) and Deputy in front of Health Authorities. We maintained and updated the PSMF bi-annually and revised the client’s SOPs as needed. Our team conducted bibliographic searches and regulatory intelligence, managed suspected adverse reaction cases via the Vigilazierta database, and maintained the XeVMPD. We updated SDEAs, conducted third-party audits, and prepared comprehensive safety reports including PSURs, RMPs, ACOS, signal detection…

    Additionally, we provided on-demand support for health authority responses, expert medical advice, audit and inspection assistance, and annual PV training.

    结果

    QbD Group's pharmacovigilance partnership delivers results!

    Partnering with QbD Group for Pharmacovigilance (PV) activities led to a successful inspection outcome by the local Regulatory Authority (AEMPS). The effective project management provided by QbD Group instilled total confidence and peace of mind. Additionally, this partnership facilitated cross-selling across various QbD services, including the introduction of 10 new cosmetics under Cosmetovigilance and the implementation of a new Regulatory Affairs (RA) dictionary.

    QbD Group

    Ready to take the next step?

    准备加速您的生命科学项目?与我们的专家交流。

    获取专家指导 →
    分享本文

    继续阅读

    相关内容

    我们使用 Cookie 来改善您的体验

    我们使用必要的 Cookie 来保证网站功能,以及可选的分析 Cookie 来改善我们的服务。 阅读我们的 隐私政策Cookie 政策.